Company registration number 04525695 (England and Wales)
ABBOTSLEY VETERINARY PRACTICE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JULY 2025
PAGES FOR FILING WITH REGISTRAR
ABBOTSLEY VETERINARY PRACTICE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
ABBOTSLEY VETERINARY PRACTICE LIMITED (REGISTERED NUMBER: 04525695)
BALANCE SHEET
AS AT 31 JULY 2025
31 July 2025
- 1 -
31 July 2025
31 March 2025
Notes
£
£
£
£
Current assets
Cash at bank and in hand
2,000
77,732
Creditors: amounts falling due within one year
3
(1,985)
(1,985)
Net current assets
15
75,747
Capital and reserves
Called up share capital
4
2
2
Profit and loss reserves
13
75,745
Total equity
15
75,747

For the financial period ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 4 August 2025 and are signed on its behalf by:
P Foxell
Director
ABBOTSLEY VETERINARY PRACTICE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JULY 2025
- 2 -
1
Accounting policies
Company information

Abbotsley Veterinary Practice Limited is a private company limited by shares incorporated in England and Wales. The registered office is 3 Clare Lane, East Malling, Kent, ME19 6BN.

1.1
Reporting period

The company accounts are presented for a period shorter than a year, covering the period from the 1st of April 2025 to the 31st of July 2025.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £1.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
2025
Number
Number
Total
2
2
3
Creditors: amounts falling due within one year
2025
2025
£
£
Other creditors
1,985
1,985
ABBOTSLEY VETERINARY PRACTICE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 JULY 2025
- 3 -
4
Called up share capital
2025
2025
2025
2025
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
1
1
1
1
Ordinary A of £1 each
1
1
1
1
2
2
2
2
2025-07-312025-04-01falsefalsefalse04 August 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityP FoxellMrs K FoxellMrs K Foxell045256952025-04-012025-07-31045256952025-07-31045256952025-03-3104525695core:ShareCapital2025-07-3104525695core:ShareCapital2025-03-3104525695core:RetainedEarningsAccumulatedLosses2025-07-3104525695core:RetainedEarningsAccumulatedLosses2025-03-3104525695core:ShareCapitalOrdinaryShareClass12025-07-3104525695core:ShareCapitalOrdinaryShareClass12025-03-3104525695core:ShareCapitalOrdinaryShareClass22025-07-3104525695core:ShareCapitalOrdinaryShareClass22025-03-3104525695core:ShareCapitalOrdinaryShares2025-07-3104525695core:ShareCapitalOrdinaryShares2025-03-3104525695bus:Director12025-04-012025-07-31045256952024-04-012025-03-3104525695core:CurrentFinancialInstruments2025-07-3104525695core:CurrentFinancialInstruments2025-03-3104525695bus:OrdinaryShareClass12025-04-012025-07-3104525695bus:OrdinaryShareClass22025-04-012025-07-3104525695bus:OrdinaryShareClass12025-07-3104525695bus:OrdinaryShareClass12025-03-3104525695bus:OrdinaryShareClass22025-07-3104525695bus:OrdinaryShareClass22025-03-3104525695bus:AllOrdinaryShares2025-07-3104525695bus:AllOrdinaryShares2025-03-3104525695bus:PrivateLimitedCompanyLtd2025-04-012025-07-3104525695bus:SmallCompaniesRegimeForAccounts2025-04-012025-07-3104525695bus:FRS1022025-04-012025-07-3104525695bus:AuditExemptWithAccountantsReport2025-04-012025-07-3104525695bus:Director22025-04-012025-07-3104525695bus:CompanySecretary12025-04-012025-07-3104525695bus:FullAccounts2025-04-012025-07-31xbrli:purexbrli:sharesiso4217:GBP